ETF Managers Group LLC increased its position in shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT – Get Rating) by 308.9% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 172,386 shares of the company’s stock after acquiring an additional 130,225 shares during the period. ETF Managers […]